| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Van Houte Hans is a Chief Financial Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $885K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,330 | $39.93 | $212,839.16 | -100% | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 13,583 | $35.46 | $481,621.05 | -42.1% |